1 |
Shin JI, Park JM, Shin YH, Hwang DH, Kim JH, Lee JS. Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schonlein purpura. Scand J Rheumatol 2006;35:56-60.
DOI
ScienceOn
|
2 |
Tarshish P, Bernstein J, Edelmann CM Jr. Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol 2004;19:51-6.
DOI
ScienceOn
|
3 |
Flynn JT, Smoyer WE, Bunchman TE, Kershaw DB, Sedman AB. Treatment of Henoch-Schonlein Purpura glomerulone phritis in children with high-dose corticosteroids plus oral cyclophosphamide. Am J Nephrol 2001;21:128-33.
DOI
ScienceOn
|
4 |
Singh S, Devidayal, Kumar L, Joshi K, Minz RW, Datta U. Severe Henoch-Schonlein nephritis: resolution with azathioprine and steroids. Rheumatol Int 2002;22:133-7.
DOI
ScienceOn
|
5 |
Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schonlein glomerulonephritis. Pediatr Nephrol 2003;18:1138-42.
DOI
ScienceOn
|
6 |
Chang WL, Yang YH, Wang LC, Lin YT, Chiang BL. Renal manifestations in Henoch- Schonlein purpura: a 10-year clinical study. Pediatr Nephrol 2005;20:1269-72.
DOI
ScienceOn
|
7 |
Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ, Kim HS. Serum IgA/C3 ratio may be a useful marker of disease activity in severe Henoch-Schonlein nephritis. Nephron Clin Pract 2005;101:c72-8.
DOI
ScienceOn
|
8 |
Hattori M, Ito K, Konomoto T, Kawaguchi H, Yoshioka T, Khono M. Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schonlein purpura nephritis in children. Am J Kidney Dis 1999;33:427-33.
DOI
ScienceOn
|
9 |
Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr Nephrol 1999;13:816-23.
DOI
ScienceOn
|
10 |
Shin JI, Park JM, Lee JS, Kim JH, Kim PK, Jeong HJ. Successful use of cyclosporin A in severe Schonlein-Henoch nephritis resistant to both methylprednisolone pulse and azathioprine. Clin Rheumatol 2006;25: 759-60.
DOI
ScienceOn
|
11 |
Watanabe T, Takahashi S, Nakajo S, Hamasaki M. Pathological improvement of IgA nephropathy and Henoch-Schonlein purpura nephritis with urokinase therapy. Acta Pae diatr Jpn 1996;38:622-8.
DOI
|
12 |
Shin JI, Park JM, Shin YH, Kim JH, Kim PK, Lee JS, et al. Cyclosporin A therapy for severe Henoch-Schonlein nephritis with nephrotic syndrome. Pediatr Nephrol 2005; 20:1093-7.
DOI
ScienceOn
|
13 |
Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch-Schonlein purpura. Pediatr Nephrol 2003;18:471-3.
|
14 |
Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. Henoch-Schonlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment. Scand J Rheumatol 2005;34:392-5.
DOI
ScienceOn
|
15 |
Kawasaki Y, Suzuki J, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study. Nephrol Dial Transplant 2004;19: 858-64.
DOI
|
16 |
Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin Nephrol 1998;49:9-14.
|
17 |
Foster BJ, Bernard C, Drummond KN, Sharma AK. Effective therapy for severe Henoch- Schonlein purpura nephritis with prednisone and azathioprine: a clinical and histopathological study. J Pediatr 2000;136: 370-5.
DOI
ScienceOn
|
18 |
Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, et al. Can azathioprine and steroids alter the progression of severe Henoch-Schonlein nephritis in children? Pediatr Nephrol 2005;20:1087-92.
DOI
ScienceOn
|
19 |
Tanaka H, Suzuki K, Nakahata T, Ito E, Waga S. Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis. Pediatr Nephrol 2003;18:347-50.
|
20 |
Oner A, Tinaztepe K, Erdogan O. The effect of triple therapy on rapidly progressive type of Henoch-Schonlein nephritis. Pediatr Nephrol 1995;9:6-10.
DOI
ScienceOn
|
21 |
Iijima K, Ito-Kariya S, Nakamura H, Yoshikawa N. Multiple combined therapy for severe Henoch-Schonlein nephritis in children. Pediatr Nephrol 1998;12:244-8.
DOI
ScienceOn
|
22 |
Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schonlein nephritis. Pediatrics 2003;111:785-9.
DOI
ScienceOn
|
23 |
Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Factors affecting histological regression of crescentic Henoch-Schonlein nephritis in children. Pediatr Nephrol 2006;21:54-9.
DOI
ScienceOn
|
24 |
Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch nephritis. Pediatr Nephrol 1998;12:238-43.
DOI
ScienceOn
|
25 |
Meadow SR, Glasgow EF, White RHR, Moncrief W, Cameron JS, Ogg CS. Schonlein-Henoch nephritis. Q J Med 1972;41:241-58.
|
26 |
Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, et al. Clinical and pathological features of children with Henoch Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 2003;60:153-60.
DOI
|
27 |
Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F. Clinical outcome in children with Henoch-Schonlein nephritis. Pediatr Nephrol 2007;22:64-70.
DOI
ScienceOn
|
28 |
Rieu P, Noel LH. Henoch-Schonlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne (Paris) 1999;150:151-9.
|
29 |
Wyatt RJ, Hogg RJ. Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 2001;16:156-67.
DOI
ScienceOn
|
30 |
Yoshikawa N, Tanaka R, Iijima K. Pathophysiology and treatment of IgA nephropathy in children. Pediatr Nephrol 2001;16:446-57.
DOI
ScienceOn
|
31 |
Schonlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 2005;20:46-51.
DOI
ScienceOn
|
32 |
Ronkainen J, Ala-Houhala M, Huttunen NP, Jahnukainen T, Koskimies O, ormala T, et al. Outcome of Henoch-Schonlein nephritis with nephrotic-range proteinuria. Clin Nephrol 2003;60:80-4.
DOI
|
33 |
Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001;357:1601-8.
DOI
ScienceOn
|
34 |
Kaku Y, Nohara K, Honda S. Renal involvement in Henoch-Schonlein purpura: a multivariate analysis of prognostic factors. Kidney Int 1998;53:1755-9.
DOI
ScienceOn
|
35 |
Goldstein AR, White RHR, Akuse R, Chantler C. Long-term follow-up of childhood Henoch- Schönlein nephritis. Lancet 1992;339: 280-2.
DOI
ScienceOn
|
36 |
Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schonlein purpura. A retrospective cohort study. Lancet 2002;360:666-70.
DOI
ScienceOn
|
37 |
Rostoker G. Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs 2001;15: 99-138.
DOI
ScienceOn
|
38 |
Sano H, Izumida M, Shimizu H, Ogawa Y. Risk factors of renal involvement and significant proteinuria in Henoch-Schonlein purpura. Eur J Pediatr 2002;161:196-201.
DOI
ScienceOn
|
39 |
Davin J-C, Weening JJ. Henoch-Schonlein purpura nephritis: an update. Eur J Pediatr 2001;160:689-95.
DOI
|
40 |
Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005;90: 916-20.
DOI
ScienceOn
|
41 |
Koskimies O, Mir S, Rapola J, Vilska J. Henoch-Schönlein nephritis: long-term prognosis of unselected patients. Arch Dis Child 1981;56:482-4.
DOI
ScienceOn
|
42 |
Wortmann SB, Fiselier TJ, Van De Kar NC, Aarts RA, Warris A, Draaisma JM. Refractory severe intestinal vasculitis due to Henoch-Schonlein purpura: successful treatment with plasmapheresis. Acta Paediatr 2006;95:622-3.
DOI
ScienceOn
|
43 |
Camacho Diaz JA, Gimenez Llort A, Garcia Garcia L, Jimenez Gonzalez R. Long-term effect of angiotensin-converting inhibitors in children with proteinuria. An Esp Pediatr 2001;55:219-24.
DOI
|
44 |
Dixit MP, Dixit NM, Scott K. Managing Henoch-Schonlein purpura in children with fish oil and ACE inhibitor therapy. Nephrology (Carlton) 2004;9:381-6.
DOI
ScienceOn
|
45 |
Shin JI, Park JM, Kim JH, Lee JS, Jeong HJ. Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schonlein nephritis. Scand J Rheumatol 2006;35:162-3.
DOI
ScienceOn
|
46 |
Kawasaki Y, Suzuki J, Murai M, Takahashi A, Isome M, Nozawa R, et al. Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis. Pediatr Nephrol 2004; 19:920-3.
|
47 |
Wright E, Dillon MJ, Tullus K. Childhood vasculitis and plasma exchange. Eur J Pediatr 2007;166:145-51.
|
48 |
Wen YK, Yang Y, Chang CC. Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schonlein purpura treated with plasmapheresis. Pediatr Nephrol 2005;20: 223-5.
DOI
ScienceOn
|
49 |
Yamamoto-Shuda Y, Nakayama K, Saito T, Natori Y. Therapeutic effect of glucocorticoid on experimental crescentic glomerulonephritis. J Lab Clin Med 1999;134:410-8.
DOI
ScienceOn
|
50 |
Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, et al. Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 2006;47: 993-1003
DOI
ScienceOn
|
51 |
Chan JC, Trachtman H. Modulating the progression in IgA nephropathy. Nephron Clin Pract 2006;104:c61-8.
DOI
ScienceOn
|
52 |
Shin JI, Park JM, Shin YH, Lee JS, Jeong HJ. Role of mesangial fibrinogen deposition in the pathogenesis of crescentic Henoch-Schonlein nephritis in children. J Clin Pathol 2005;58:1147-51.
DOI
ScienceOn
|